LMG Life Sciences Names Robins Kaplan Partner Jake Holdreith ‘General Patent Litigator of the Year’

October 1, 2015

The annual LMG Life Sciences awards recognize leading attorneys, law firms, and in-house counsel teams that have played a significant role in the life sciences industry over the last 12 months. Winners were selected based on research involving feedback from clients in the industry, nearly 1,000 interviews and surveys by partners active in the United States, and reviews of public information. According to the publication, this process led to the selection of the “highest profile, most sought-after and best attorneys working in life sciences.”

Mr. Holdreith leads Robin Kaplan’s Health and Life Sciences Industry Group and is well-known as strategist, trusted counselor and able courtroom lawyer. He has tried jury cases to multi-million dollar verdicts, and has resolved complex cases at all stages of litigation.

Mr. Holdreith has been named a "Life Sciences Star" by LMG Life Sciences since 2012. To learn more about Mr. Holdreith's practice and successes, please review his full bio

Jake M. Holdreith

Partner

Managing Partner, Minneapolis Office
Member of Executive Board

Related Publications

Second Quarter
GENERICally Speaking: A Hatch-Waxman Litigation Bulletin
Oren Langer, Christopher Pinahs, Emily Tremblay, and Christine May
June 25, 2024
Amarin Pharma, Inc. v. Hikma Pharms. USA Inc.
GENERICally Speaking Hatch Waxman Bulletin
June 10, 2024
Teva Branded Pharm. Products R&D, Inc. v. Amneal Pharms. of NY, LLC
GENERICally Speaking Hatch Waxman Bulletin
April 30, 2024
Pharmacyclics LLC v. Alvogen Pine Brook LLC
GENERICally Speaking Hatch Waxman Bulletin
First Quarter
GENERICally Speaking: A Hatch-Waxman Litigation Bulletin
Oren Langer, Christopher Pinahs, Emily Tremblay, and Christine May
Back to Top